Corticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report.

Shimizu H, Shimizu T, Takahashi D, Asano T, Arai R, Takakuwa Y, Iwasaki N

Open source

DOI
10.1186/s12891-019-2468-5
Published
2019 Feb 19
Container
BMC musculoskeletal disorders
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12891-019-2468-5,
  title = {Corticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report.},
  author = {Shimizu H and Shimizu T and Takahashi D and Asano T and Arai R and Takakuwa Y and Iwasaki N},
  year = {2019},
  journal = {BMC musculoskeletal disorders},
  doi = {10.1186/s12891-019-2468-5},
  url = {https://doi.org/10.1186/s12891-019-2468-5}
}

RIS

TY  - JOUR
TI  - Corticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report.
AU  - Shimizu H
AU  - Shimizu T
AU  - Takahashi D
AU  - Asano T
AU  - Arai R
AU  - Takakuwa Y
AU  - Iwasaki N
PY  - 2019
JO  - BMC musculoskeletal disorders
DO  - 10.1186/s12891-019-2468-5
UR  - https://doi.org/10.1186/s12891-019-2468-5
ER  - 

APA

H, S., T, S., D, T., T, A., R, A., Y, T., & N, I. (2019). Corticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report.. BMC musculoskeletal disorders. https://doi.org/10.1186/s12891-019-2468-5

Source records